vs
Vita Coco Company, Inc.（COCO）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Vita Coco Company, Inc.的1.1倍（$197.9M vs $179.8M），Vita Coco Company, Inc.净利率更高（17.0% vs 6.7%，领先10.2%），Vita Coco Company, Inc.同比增速更快（37.3% vs 13.6%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 11.7%）
唯他可可（Vita Coco）是美国知名饮料企业，主打椰子水产品，是全球椰子水及植物基饮品赛道的头部品牌。截至2016年业务已覆盖31个国家，属于共益企业，由All Market Inc.控股。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
COCO vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$179.8M
营收增速更快
COCO
高出23.7%
13.6%
净利率更高
COCO
高出10.2%
6.7%
两年增速更快
RGEN
近两年复合增速
11.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $179.8M | $197.9M |
| 净利润 | $30.5M | $13.3M |
| 毛利率 | 39.9% | 52.5% |
| 营业利润率 | 18.7% | 9.0% |
| 净利率 | 17.0% | 6.7% |
| 营收同比 | 37.3% | 13.6% |
| 净利润同比 | 61.4% | 143.9% |
| 每股收益（稀释后） | $0.50 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COCORGEN
| Q1 26 | $179.8M | — | ||
| Q4 25 | $127.8M | $197.9M | ||
| Q3 25 | $182.3M | $188.8M | ||
| Q2 25 | $168.8M | $182.4M | ||
| Q1 25 | $130.9M | $169.2M | ||
| Q4 24 | $127.3M | $174.1M | ||
| Q3 24 | $132.9M | $154.9M | ||
| Q2 24 | $144.1M | $154.1M |
净利润COCORGEN
| Q1 26 | $30.5M | — | ||
| Q4 25 | $5.5M | $13.3M | ||
| Q3 25 | $24.0M | $14.9M | ||
| Q2 25 | $22.9M | $14.9M | ||
| Q1 25 | $18.9M | $5.8M | ||
| Q4 24 | $3.4M | $-30.3M | ||
| Q3 24 | $19.3M | $-654.0K | ||
| Q2 24 | $19.1M | $3.3M |
毛利率COCORGEN
| Q1 26 | 39.9% | — | ||
| Q4 25 | 34.9% | 52.5% | ||
| Q3 25 | 37.7% | 53.2% | ||
| Q2 25 | 36.3% | 50.0% | ||
| Q1 25 | 36.7% | 53.6% | ||
| Q4 24 | 32.5% | 26.1% | ||
| Q3 24 | 38.8% | 50.0% | ||
| Q2 24 | 40.8% | 49.8% |
营业利润率COCORGEN
| Q1 26 | 18.7% | — | ||
| Q4 25 | 8.0% | 9.0% | ||
| Q3 25 | 15.3% | 8.9% | ||
| Q2 25 | 14.9% | 7.6% | ||
| Q1 25 | 14.7% | 3.9% | ||
| Q4 24 | 3.4% | -17.7% | ||
| Q3 24 | 15.5% | -5.1% | ||
| Q2 24 | 20.8% | 1.0% |
净利率COCORGEN
| Q1 26 | 17.0% | — | ||
| Q4 25 | 4.3% | 6.7% | ||
| Q3 25 | 13.2% | 7.9% | ||
| Q2 25 | 13.6% | 8.2% | ||
| Q1 25 | 14.4% | 3.4% | ||
| Q4 24 | 2.6% | -17.4% | ||
| Q3 24 | 14.5% | -0.4% | ||
| Q2 24 | 13.2% | 2.2% |
每股收益（稀释后）COCORGEN
| Q1 26 | $0.50 | — | ||
| Q4 25 | $0.10 | $0.24 | ||
| Q3 25 | $0.40 | $0.26 | ||
| Q2 25 | $0.38 | $0.26 | ||
| Q1 25 | $0.31 | $0.10 | ||
| Q4 24 | $0.06 | $-0.55 | ||
| Q3 24 | $0.32 | $-0.01 | ||
| Q2 24 | $0.32 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $201.9M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $352.2M | $2.1B |
| 总资产 | $488.3M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资COCORGEN
| Q1 26 | $201.9M | — | ||
| Q4 25 | $196.9M | $767.6M | ||
| Q3 25 | $203.7M | $748.7M | ||
| Q2 25 | $167.0M | $708.9M | ||
| Q1 25 | $153.6M | $697.2M | ||
| Q4 24 | $164.7M | $757.4M | ||
| Q3 24 | $156.7M | $784.0M | ||
| Q2 24 | $150.1M | $809.1M |
总债务COCORGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益COCORGEN
| Q1 26 | $352.2M | — | ||
| Q4 25 | $331.5M | $2.1B | ||
| Q3 25 | $323.7M | $2.1B | ||
| Q2 25 | $296.9M | $2.1B | ||
| Q1 25 | $277.9M | $2.0B | ||
| Q4 24 | $258.8M | $2.0B | ||
| Q3 24 | $252.1M | $2.0B | ||
| Q2 24 | $232.0M | $2.0B |
总资产COCORGEN
| Q1 26 | $488.3M | — | ||
| Q4 25 | $461.2M | $2.9B | ||
| Q3 25 | $461.3M | $2.9B | ||
| Q2 25 | $421.1M | $2.9B | ||
| Q1 25 | $384.0M | $2.9B | ||
| Q4 24 | $362.4M | $2.8B | ||
| Q3 24 | $353.1M | $2.8B | ||
| Q2 24 | $323.0M | $2.9B |
负债/权益比COCORGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流COCORGEN
| Q1 26 | — | — | ||
| Q4 25 | $-3.9M | $25.7M | ||
| Q3 25 | $39.1M | $48.1M | ||
| Q2 25 | $21.8M | $28.6M | ||
| Q1 25 | $-9.8M | $15.0M | ||
| Q4 24 | $6.9M | $39.2M | ||
| Q3 24 | $9.3M | $49.3M | ||
| Q2 24 | $26.9M | $42.2M |
自由现金流COCORGEN
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | $17.6M | ||
| Q3 25 | $35.6M | $43.4M | ||
| Q2 25 | $20.9M | $21.5M | ||
| Q1 25 | $-10.4M | $11.4M | ||
| Q4 24 | $6.8M | $33.6M | ||
| Q3 24 | $8.9M | $42.3M | ||
| Q2 24 | $26.6M | $37.4M |
自由现金流率COCORGEN
| Q1 26 | — | — | ||
| Q4 25 | -5.6% | 8.9% | ||
| Q3 25 | 19.6% | 23.0% | ||
| Q2 25 | 12.4% | 11.8% | ||
| Q1 25 | -7.9% | 6.8% | ||
| Q4 24 | 5.3% | 19.3% | ||
| Q3 24 | 6.7% | 27.3% | ||
| Q2 24 | 18.5% | 24.3% |
资本支出强度COCORGEN
| Q1 26 | — | — | ||
| Q4 25 | 2.5% | 4.1% | ||
| Q3 25 | 1.9% | 2.5% | ||
| Q2 25 | 0.6% | 3.9% | ||
| Q1 25 | 0.4% | 2.1% | ||
| Q4 24 | 0.1% | 3.2% | ||
| Q3 24 | 0.3% | 4.5% | ||
| Q2 24 | 0.2% | 3.1% |
现金转化率COCORGEN
| Q1 26 | — | — | ||
| Q4 25 | -0.70× | 1.93× | ||
| Q3 25 | 1.63× | 3.23× | ||
| Q2 25 | 0.95× | 1.92× | ||
| Q1 25 | -0.52× | 2.57× | ||
| Q4 24 | 2.05× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 1.41× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COCO
| Subtotal | $148.2M | 82% |
| Private Label | $24.4M | 14% |
| Other | $7.2M | 4% |
RGEN
暂无分部数据
